Asia Pacific Antacids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Dosage Form (Tablet, Liquid, and Others); Drug Class (Proton Pump Inhibitors, H2 Antagonist, and Acid Neutralizers); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
Market Introduction
The class of drugs that neutralize the acid in the stomach are known as antacids. It is used to treat conditions like heartburn, indigestion, acidity and an upset stomach. These drugs are available over the counter and are usually consumed by mouth. They are available in tablets, capsules, liquid and powder form. There are different types of antacid available like aluminium hydroxide, magnesium carbonate, magnesium trisilicate, magnesium hydroxide, calcium carbonate, and sodium bicarbonate.
Get more information on this report :
Market Overview and Dynamics
The Asia Pacific antacids market is expected to reach US$ 3,255.05 million in 2027 from US$ 2,287.19 million in 2019. The market is estimated to grow with a CAGR of 4.6% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as the increasing innovative product launches by market players and the higher incidence of the obese population. However, the market is expected experiencing slow growth during the forecast period owing to the stringent regulatory norms and several challenges associated with gastrointestinal diseases.
Key Market Segments
Based on dosage form, the antacids market is segmented into tablet, liquid, and others. Based on drug class, the antacids market is segmented into proton pump inhibitors, H2 antagonist, and acid neutralizers. Based on distribution channel, the antacids market, is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.
Major Sources and Companies Listed
Some of the major primary and secondary sources for antacids market included in the report are National Center for Health Statistics (NCHS), the India Brand Equity Foundation (IBEF), the Australian Self Medication Industry (ASMI), and others.
Reasons to buy the report
- To understand the Asia Pacific antacids market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for antacids market
- Efficiently plan M&A and partnership deals in Asia Pacific antacids market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form antacids market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in Asia Pacific region
ASIA PACIFIC ANTACIDS MARKET SEGMENTATION
- Tablet
- Liquid
- Others
By Drug Class
- Proton Pump Inhibitors
- H2 Antagonist
- Acid Neutralizers
- Magaldrate
- Sucralfate
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Country
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Company Profiles
- Bayer AG
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Sun Pharmaceutical Industries Ltd
- Sanofi
- Boehringer Ingelheim International GmbH
- Dr. Reddy's Laboratories
- Pfizer Inc
- Reckitt Benckiser Group Plc
- Procter & Gamble
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Antacid Market – By Dosage Form
1.3.2 Antacid Market – By Drug Class
1.3.3 Antacid Market – By Distribution Channel
1.3.4 Asia Pacific Antacid Market – By Country
2. Asia Pacific Antacid Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Antacid Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Antacid Market- Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Antacid Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Innovative Product Launches by Market Players
5.1.2 Higher Incidence of the Obese Population
5.2 Market Restraints
5.2.1 Stringent Regulatory Norms and Several Challenges Associated with Gastrointestinal Diseases
5.3 Market Opportunities
5.3.1 Increasing Demand for OTC (Over the Counter) Antacid Medications
5.4 Future Trends
5.4.1 Rising Development of the Pharmaceutical Industry
5.5 Impact Analysis
6. Antacid Market – Asia Pacific Analysis
6.1 Asia Pacific Antacid Market Revenue Forecasts and Analysis
7. Asia Pacific Antacid Market Analysis and Forecasts to 2027 – By Dosage Form
7.1 Overview
7.2 Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
7.3 Tablet
7.3.1 Overview
7.3.2 Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Liquid
7.4.1 Overview
7.4.2 Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8. Asia Pacific Antacid Market Analysis and Forecasts to 2027– By Drug Class
8.1 Overview
8.2 Antacid Market Revenue Share, by Drug Class (2019 and 2027)
8.3 Proton Pump Inhibitors
8.3.1 Overview
8.3.2 Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.4 H Antagonist
8.4.1 Overview
8.4.2 H Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Acid Neutralizers
8.5.1 Overview
8.5.2 Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.3 Magaldrate
8.5.3.1 Overview
8.5.3.2 Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.4 Sucralfate
8.5.4.1 Overview
8.5.4.2 Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.5 Others
8.5.5.1 Overview
8.5.5.2 Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9. Asia Pacific Antacid Market Analysis and Forecasts to 2027– By Distribution Channel
9.1 Overview
9.2 Antacid Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
10. Antacid Market Revenue and Forecasts to 2027 – Geographical Analysis
10.1 Asia-Pacific: Antacid Market
10.1.1 Overview
10.1.2 Asia-Pacific: Antacid Market, by Country, 2019 & 2027 (%)
10.1.3 China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)
10.1.3.1 China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)
10.1.3.2 China: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.3.3 China: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.3.3.1 China: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.3.4 China: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.4 Japan: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.1 Japan: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.2 Japan: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.4.3 Japan: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.4.3.1 Japan: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.4.4 Japan: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.5 India: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.1 India: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.2 India: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.5.3 India: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.5.4 India: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.5.5 India: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.1 South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.2 South Korea: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.6.3 South Korea: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.6.3.1 South Korea: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.6.4 South Korea: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.7 Australia: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Australia: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Australia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Australia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.7.3.1 Australia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Australia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Rest of Asia Pacific: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Rest of Asia Pacific: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.1.8.3.1 Rest of Asia Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Rest of Asia Pacific: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact Of COVID-19 Pandemic on Asia Pacific Antacid Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. COMPANY PROFILES
13.1 Bayer AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takeda Pharmaceutical Company Limited
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sun Pharmaceutical Industries Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sanofi
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Boehringer Ingelheim International GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Dr. Reddy's Laboratories
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Pfizer Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 roducts and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Reckitt Benckiser Group Plc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Procter & Gamble
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 2. China: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 3. China: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 4. China: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. Japan: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 6. Japan: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 7. Japan: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 8. Japan: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. India: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 10. India: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 11. India: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 12. India: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. South Korea: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 14. South Korea: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 15. South Korea: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 16. South Korea: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 17. Australia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 18. Australia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 19. Australia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 20. Australia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 21. Rest of Asia Pacific: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 22. Rest of Asia Pacific: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 23. Rest of Asia Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 24. Rest of Asia Pacific: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 25. Organic Developments Done By Companies
Table 26. Inorganic Developments Done By Companies
Table 27. Glossary of Terms, Antacid Market
LIST OF FIGURES
Figure 1. Antacid Market Segmentation
Figure 2. Asia Pacific Antacid Market Overview
Figure 3. Tablet Segment Held Largest Share of Dosage Form in Antacid Market
Figure 4. Proton Pump Inhibitors Segment Held Largest Share of Drug Class in Antacid Market
Figure 5. Japan is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Antacid Market - Asia Pacific PEST Analysis
Figure 7. Antacid Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific Antacid Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
Figure 10. Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Antacid Market Revenue Share, by Drug Class (2019 and 2027)
Figure 14. Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. H Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Antacid Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 21. Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Asia-Pacific: Antacid Market, by Key Country – Revenue (2019) (USD Million)
Figure 25. Asia-Pacific: Antacid Market, by Country, 2019 & 2027 (%)
Figure 26. China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)
Figure 27. Japan Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. India: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Australia: Antacid – Revenue and Forecast to 2027 (USD Million)
Figure 31. Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 33. Growth Strategies Done by the Companies in the Market, (%)
- Bayer AG
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Sun Pharmaceutical Industries Ltd
- Sanofi
- Boehringer Ingelheim International GmbH
- Dr. Reddy's Laboratories
- Pfizer Inc
- Reckitt Benckiser Group Plc
- Procter & Gamble
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific antacids market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific antacids market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.